Revealing the path of a metallodrug in a breast cancer cell

VIDEO: Scientists from ESRF, the European synchrotron, Inserm, CNRS, Sorbonne University, PSL university, University Grenoble Alpes arevealed the path of a metallodrug in a breast cancer cell view more  Some types of cancer cannot be treated with classical chemotherapy. Scientists from Inserm, CNRS, Sorbonne University, PSL university, University Grenoble Alpes and ESRF, the European Synchrotron, are…

Details

Higher lifetime risk of sudden cardiac death among African Americans may be associated with income and education disparities

DALLAS, Feb. 4, 2019 — African Americans – especially African American women – have a significantly higher risk of sudden cardiac death during their lifetime than whites, and much of the disparity can be attributed to income and education levels, according to new research in the American Heart Association’s journal Circulation. “We wanted to explain…

Details

Rutgers study finds rise in overdoses from opioids in diarrhea drug

A Rutgers study has uncovered a new threat in the opiate epidemic: Overdoses of loperamide, an over-the-counter diarrhea medication, have been steadily increasing in number and severity nationwide over five years. Misuse of the drug is particularly alarming because non-prescription drugs like loperamide are inexpensive, readily available online and in retail stores, undetectable on routine…

Details

University spinout receives £1.2 million to tackle antimicrobial resistance

IMAGE: This is Mathew Upton, Professor of Medical Microbiology at the University of Plymouth, and Chief Scientific Officer at Amprologix Limited. view more  Credit: University of Plymouth Amprologix Limited, a University of Plymouth spinout company, has won a £1.2 million contract from the Department for Health and Social Care to accelerate development and scale up its…

Details

Ohio State-led study links protein, clusterin, to cardiac and metabolic diseases

COLUMBUS, Ohio – During a study spanning nearly a decade, researchers at The Ohio State University College of Medicine, Houston Methodist Research Institute and Houston Methodist Cancer Center have linked the protein clusterin – for the first time — to many different facets of cardiometabolic syndrome risk through its actions in the liver. Cardiometabolic syndrome…

Details